简体中文
Science & Technologies / Newsroom / Ordering Info / Career / Contact Us
Products Services Quality System Culture About Us
中文 / English
Login Register

Newsroom

Home Newsroom CHO CD02, CHO CD04, and CHO Feed02 were launched
News

May 1, 2018

CHO CD02, CHO CD04, and CHO Feed02 were launched










Latest Articles
News June 25, 2021

Dr. Poon, CEO of QuaCell Biotechnology, Co., Ltd. was honored to be elected Associate Editor of RE: GEN Open

June 25, 2021 / Quacell Newsroom /- Dr. Poon, CEO of Quacell Biotechnology Co., Ltd. was invited by Re: Gen Open to be selected as Associate Editor.
Learn More
News May 25, 2021

Conclusion | Biofuture2021

The two-day Biofuture 2021 Next Generation Antibody Drug Technology Innovation Conference & Cell and Gene Therapy Innovation Conference came to a successful conclusion.
Learn More
News May 21, 2021

BIG EVENETS. Day 2 | Biofuture 2021

Quacell Biotechnology will continue to show you more latest information about our products in the #B21 booth
Learn More
News May 20, 2021

BIG EVENETS. Day 1 | Biofuture 2021

Biofuture 2021 Next Generation Antibody Drug Technology Innovation Conference & Cell and Gene Therapy Innovation Conference held in Crowne Plaza Shanghai Jiangong Pujiang Hotel
Learn More
News May 11, 2021

Wayne293™ Transient medium was launched

Wayne293™ Transient Medium: One-step expression of desired proteins
Learn More
News May 11, 2021

CHO CD02, CHO CD04, and CHO Feed02 were launched

QuaCell Biotechnology’s three new products were officially launched, namely CHO CD02, CHO CD04, and CHO Feed02.
Learn More